HEARTFLOW INC

Insightful analysis of HEARTFLOW Inc.’s 10b5‑1 insider trades reveals disciplined buying and strategic selling amid a rising 48% YTD stock rally, underscoring confidence in its cardiovascular pipeline and market position.

HeartFlow insider buying sparks optimism as CMO Rogers Campbell buys 99k shares, signaling confidence amid CFO sales and strong 40% earnings growth.

Heartflow CFO’s recent share sales signal a strategic shift, not panic—watch for future moves and earnings for clues.

Heartflow CFO’s recent insider selling signals liquidity needs, not a sell‑off alarm, while the company’s AI‑driven cardiovascular tech gains traction in value‑based care markets.